Categories AlphaGraphs, Earnings, Health Care
Abbott Laboratories (ABT) Q3 2024 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported third quarter 2024 earnings results today.
Total reported sales increased 4.9% year-over-year to $10.6 billion. Organic sales growth was 7.6%.
Net earnings increased 14.6% to $1.64 billion, or $0.94 per share, compared to last year. Adjusted EPS rose 6.1% to $1.21.
Abbott expects GAAP EPS of $3.34-3.40 and adjusted EPS of $4.64-4.70 for full-year 2024. For the fourth quarter of 2024, the company expects GAAP EPS of $0.96-1.02 and adjusted EPS of $1.31-1.37.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
United Airlines likely to continue profitable growth, despite uncertainties
United Airlines (NASDAQ: UAL) has focused its growth strategy on fleet expansion, technology adoption, and service diversification. In the new fiscal year, the company looks to leverage improving demand conditions
After a record FY24, JPMorgan prepares to report Q1 2025 earnings
JPMorgan Chase & Co. (NYSE: JPM) reported record-high revenue and profit for fiscal 2024, while continuing to expand its global footprint by optimizing operational efficiency and improving customer engagement. The
Ulta Beauty (ULTA): Here are the three main priorities in its business plan
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) were down 1% on Friday. The stock has dropped 15% over the past three months. The retailer is steering through a dynamic consumer
